Temozolomide as Maintenance Therapy in Small Cell Lung Cancer

Clinical trial NCT01900951 · UNKNOWN

Trial details

NCT number: NCT01900951
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2013-01-01
Primary completion: 2016-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.